Visibility of Oncology Pharmacists to patients

Visibility of Oncology Pharmacists to patients

VJOncology

1 year
262 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Oncology Pharmacists play an important role in the treatment and management of patients, but how visible are they to their patients? When Oncology Pharmacist, Shereen Nabhani-Gebara, PharmD, BCOP, from Kingston University, London, UK, found herself on the other side of the table, it became clear to her that while patients and their carers receive an overwhelming amount of information regarding treatments, they have limited interaction with Oncology Pharmacists. Following this experience, Dr Nabhani-Gebara developed two surveys, one for parents of children receiving cancer treatment, and the other for Oncology Pharmacists, in order to learn more about this relationship. Content on www.vjoncology.com from BOPA 2018 is supported by Napp Pharmaceuticals Ltd
Up Next Autoplay
BOPA18__VJO_Rachel Elliott_01
BOPA18__VJO_Rachel Elliott_01
Category: Acute Lymphoblastic Leukemia
0 Views
VJOncology 1 year
New models for patient care: advanced pharmacy practitioners
New models for patient care: advanced pharmacy practitioners
Category: General
820 Views
VJOncology 1 year
Patient symptom and experience trackers
Patient symptom and experience trackers
Category: General
587 Views
VJOncology 1 year
Update from the Scottish Cancer Medicines Outcome Programme
Update from the Scottish Cancer Medicines Outcome Programme
Category: General
581 Views
VJOncology 1 year
The switch to biosimilar rituximab at UCH: 12 months on
The switch to biosimilar rituximab at UCH: 12 months on
Category: Lymphoma
562 Views
VJOncology 1 year
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
Category: General
368 Views
VJOncology 1 year
Smart app to allow patients to manage their side effects independently
Smart app to allow patients to manage their side effects independently
Category: Breast Cancer
80 Views
VJOncology 1 year
cancer-druginteractions.org: a comprehensive tool for HCPs
cancer-druginteractions.org: a comprehensive tool for HCPs
Category: Other
39 Views
VJOncology 1 year
The emergence of mixed speciality oncology
The emergence of mixed speciality oncology
Category: Other
67 Views
VJOncology 1 year